ALEXANDER J. DENNER

Corporate Board Profile

Tech Score: 0/100

ENZON PHARMACEUTICALS, INC.

Filing Date	Source Excerpt
2009-04-13	Alexander J. Denner, Ph.D., serves as Managing Director of entities affiliated with Carl C. Icahn... Dr. Denner has served in this position since August 2006... The Board of Directors recommends a vote FOR Dr. Denner as Class I Director (Proposal No. 1).
2010-06-10	Alexander J. Denner, Ph.D. has served as a director since May 2009 and Chairman of the Company’s Board of Directors since July 2009. The Compensation Committee currently consists of Mr. Classon (Chairman), Dr. Denner and Messrs. Levy and Micati. The Executive Committee consists of Dr. Denner (Chairman), Professor Mulligan and Mr. Classon.
2011-04-08	Alexander J. Denner, Ph.D. has served as a director since May 2009 and Chairman of the Company 27s Board of Directors since July 2009. Dr. Denner serves as Managing Director of entities affiliated with Carl C. Icahn...Dr. Denner brings to the Board extensive experience...The Board has nominated and recommends that the stockholders elect Alexander J. Denner...Chairman of the Board...Age 41...Total Director Compensation 363,025.
2012-04-06	Alexander J. Denner has served as a director since May 2009 and Chairman of the Company 27s Board of Directors since July 2009. Dr. Denner served as Managing Director of entities affiliated with Carl C. Icahn...Dr. Denner brings to the Board extensive experience...DIRECTOR COMPENSATION FOR FISCAL YEAR ENDED DECEMBER 31, 2011: Alexander J. Denner Fees Earned or Paid in Cash ($) 78,563, Stock Awards ($) 150,002, Option Awards ($) 150,002, Total ($) 378,568.
2013-10-11	Alexander J. Denner, Richard C. Mulligan, Thomas F. Deuel, George W. Hebard III and Richard A. Young, who are currently members of the Board, will not stand for re-election at the 2013 Annual Meeting. ... Dr. Denner presided at these executive sessions. ... The Governance and Nominating Committee currently consists of Professor Mulligan (Chairman) and Dr. Denner.

Savara Inc

Filing Date	Source Excerpt
2009-04-30	Dr. Denner received his S.B. degree from the Massachusetts Institute of Technology and his M.S., M.Phil. and Ph.D. degrees from Yale University.
2009-07-23	Alexander J. Denner(5) - Consists of (a) 150,000 shares of common stock subject to options currently exercisable or exercisable within 60 days of the Evaluation Date, (b) 864,865 shares of common stock held by High River, (c) 1,660,540 shares of common stock held by Icahn Partners, (d) 1,798,919 shares of common stock held by Icahn Master, (e) 864,865 shares of common stock issuable upon exercise of warrants held by High River, (f) 1,660,540 shares of common stock issuable upon exercise of warrants held by Icahn Partners and (g) 1,798,919 shares of common stock issuable upon exercise of warrants held by Icahn Master. Dr. Denner is a Managing Director of entities affiliated with Mr. Icahn, including Icahn Partners and Icahn Master.

Filing Date

Source Excerpt

2009-04-30

Dr. Denner received his S.B. degree from the Massachusetts Institute of Technology and his M.S., M.Phil. and Ph.D. degrees from Yale University.

2009-07-23

Alexander J. Denner(5) - Consists of (a) 150,000 shares of common stock subject to options currently exercisable or exercisable within 60 days of the Evaluation Date, (b) 864,865 shares of common stock held by High River, (c) 1,660,540 shares of common stock held by Icahn Partners, (d) 1,798,919 shares of common stock held by Icahn Master, (e) 864,865 shares of common stock issuable upon exercise of warrants held by High River, (f) 1,660,540 shares of common stock issuable upon exercise of warrants held by Icahn Partners and (g) 1,798,919 shares of common stock issuable upon exercise of warrants held by Icahn Master. Dr. Denner is a Managing Director of entities affiliated with Mr. Icahn, including Icahn Partners and Icahn Master.

Data sourced from SEC filings. Last updated: 2026-02-03